The DOI matches its Crossref record; 341 of the 341 references it cites were found in a registry or an index.
Ectopic and Abnormal Hormone Receptors in Adrenal Cushing’s Syndrome*
Open accessAbstract
The mechanism by which cortisol is produced in adrenal Cushing's syndrome, when ACTH is suppressed, was previously unknown and was referred to as being "autonomous."More recently, several investigators have shown that some cortisol and other steroid-producing adrenal tumors or hyperplasias are under the control of ectopic (or aberrant, illicit, inappropriate) membrane hormone receptors.These include ectopic receptors for gastric inhibitory polypeptide (GIP), -adrenergic agonists, or LH/hCG; a similar outcome can result from altered activity of eutopic receptors, such as those for vasopressin (V1-AVPR), serotonin (5-HT 4 ), or possibly leptin.The presence of aberrant receptors places adrenal cells under stimulation by a trophic factor not negatively regulated by glucocorticoids, leading to in-creased steroidogenesis and possibly to the proliferative phenotype.The molecular mechanisms responsible for the abnormal expression and function of membrane hormone receptors are still largely unknown.Identification of the presence of these illicit receptors can eventually lead to new pharmacological therapies as alternatives to adrenalectomy, now demonstrated by the long-term control of ectopic -ARand LH/hCGR-dependent Cushing's syndrome by propanolol and leuprolide acetate.Further studies will potentially identify a larger diversity of hormone receptors capable of coupling to G proteins, adenylyl cyclase, and steroidogenesis in functional adrenal tumors and probably in other endocrine and nonendocrine tumors.(Endocrine Reviews 22: 75-110, 2001) I. Introduction II.Hormonal Regulation of the Normal Adrenal Cortex III.Primary Adrenal Cushing's Syndrome (CS) IV.Initial in Vitro Evidence of Ectopic Adrenal Membrane Hormone Receptors V.In Vivo Demonstration of the Functionality of Ectopic or Abnormal Membrane Hormone Receptors A. Food-and GIP-dependent CS B. Vasopressin-responsive CS C. Catecholamine-dependent CS D. LH-dependent CS E. LH-dependent adrenal androgen-secreting tumors F. Serotonin-responsive CS G. Steroid-responsive CS H.Other abnormal hormone responses in adrenal CS VI.Investigation Strategy A. Initial clinical screening protocol B. Further characterization of abnormal hormone receptors C. Systematic clinical screening for ectopic/abnormal hormone receptors VII.Molecular Mechanisms of Ectopic/Abnormal Hormone Receptors A. Tissue-specific expression and regulation of membrane hormone receptors B. Potential mechanisms of ectopic or abnormal hormone receptors C. Role of ectopic hormone receptors in adrenocortical cell proliferation VIII.Ectopic/Abnormal Hormone Membrane Receptors in Nonadrenocortical Tumors IX.An Opportunity for New Pharmacological Therapeutic Strategies X.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases
Karin, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16483 · Cited by 2,431
Activating Mutations of the Stimulatory G Protein in the McCune–Albright Syndrome
Weinstein, L. S., Shenker, A., Gejman, P. V., Merino, M. J., Friedman, E., & Spiegel, A. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112123252403 · Cited by 1,691
The cloning of a family of genes that encode the melanocortin receptors
Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., & Cone, R. D. (1992) · Science · doi:10.1126/science.1325670 · Cited by 1,635 · cited 2×
“ACTH binds to its G protein-coupled membrane melanocortin type 2 receptor (22, 23) to elicit short-term (acute) and long-term (chronic) specific responses, as illustrated in Fig.”
BackgroundLuo, X., Ikeda, Y., & Parker, K. L. (1994) · Cell · doi:10.1016/0092-8674(94)90211-9 · Cited by 1,631 · cited 1×
“opment and survival of steroidogenic organs, as SF-1–/– mice lack adrenal glands and gonads and exhibit male-tofemale sex reversal of their genitalia (65, 66).”
BackgroundIdentification of targets of leptin action in rat hypothalamus.
Schwartz, M. W., Seeley, R. J., Campfield, L. A., Burn, P., & Baskin, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118891 · Cited by 1,496
Landis, C. A., Masters, S. B., Spada, A., Pace, A. M., Bourne, H. R., & Vallar, L. (1989) · Nature · doi:10.1038/340692a0 · Cited by 1,441
Molecular biology of steroid hormone synthesis
MILLER, W. L. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-3-295 · Cited by 1,397
Regulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
TURNBULL, A. V., & RIVIER, C. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.1 · Cited by 1,297
β-Arrestin: a Protein that Regulates β-adrenergic Receptor Function
Lohse, M. J., Benovic, J. L., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,220
Cited by
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationFassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Self-citationNewell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Fassnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J., Pelsma, I., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad066 · Cited by 786
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
“As a result, alterations in intercellular communication through gap junctions, local production of growth factors and cytokines, and aberrant expression of ectopic receptors on adrenal tumor cells have all been implicated in adrenal cell growth, hyperplasia, tumor formation, and autonomous hormone production (13, 17,…”
BackgroundThe Lutropin/Choriogonadotropin Receptor, A 2002 Perspective
Ascoli, M., Fanelli, F., & Segaloff, D. L. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0462 · Cited by 772
10.1016/b978-1-4160-2911-3.50026-1
(2000) · CrossRef Listing of Deleted DOIs · doi:10.1016/b978-1-4160-2911-3.50026-1 · Cited by 554
AME Position Statement on adrenal incidentaloma
Terzolo, M., Stigliano, A., Chiodini, I., Loli, P., Furlani, L., Arnaldi, G., Reimondo, G., Pia, A., Toscano, V, Zini, M., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1147 · Cited by 520
Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 407
Diagnosis and Treatment of Subclinical Hypercortisolism
Chiodini, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2722 · Cited by 279
A physiologic approach to diagnosis of the Cushing syndrome.
Raff, H., & Findling, J. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-12-200306170-00010 · Cited by 186
The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors
Koch, C. A., Pacak, K., & Chrousos, G. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021069 · Cited by 177
Molecular genetics of adrenocortical tumours, from familial to sporadic diseases
Libé, R., & Bertherat, J. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02004 · Cited by 168
Libé, R., Coste, J., Guignat, L., Tissier, F., Lefebvre, H., Barrande, G., Ajzenberg, C., Tauveron, I., Clauser, E., Dousset, B., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0195 · Cited by 111
Multiple aberrant hormone receptors in Cushing’s syndrome
Ghorayeb, N. E., Bourdeau, I., & Lacroix, A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0200 · Cited by 90
Self-citationReduced nocturnal ACTH-driven cortisol secretion during critical illness
Boonen, E., Meersseman, P., Vervenne, H., Meyfroidt, G., Guïza, F., Wouters, P. J., Veldhuis, J. D., & Van den Berghe, G. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00009.2014 · Cited by 75
Primary bilateral macronodular adrenal hyperplasia
De Venanzi, A., Alencar, G. A., Bourdeau, I., Fragoso, M. C. B. V., & Lacroix, A. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000061 · Cited by 73
Self-citationReznik, Y., Lefebvre, H., Rohmer, V., Charbonnel, B., Tabarin, A., Rodien, P., Lecomte, P., Bardet, S., Coffin, C., & Mahoudeau, J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02048.x · Cited by 71
“The ectopic expression of the GIP receptor in ACTH-independent Cushing’s syndrome appears to be common in ACTH-independent macronodular adrenal hyperplasia, but is rare in unilateral adrenocortical adenomas (Lacroix et al., 2001; Groussin et al., 2002).”
BackgroundAdrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment.
Mazzuco, T. L., Bourdeau, I., & Lacroix, A. (2009) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32832b7043 · Cited by 48
Adrenocortical hyperplasia: A multifaceted disease
Bourdeau, I., Parisien-La Salle, S., & Lacroix, A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101386 · Cited by 48
Self-citationvan Aken, M. O., Pereira, A. M., van Thiel, S. W., van den Berg, G., Frölich, M., Veldhuis, J. D., Romijn, J. A., & Roelfsema, F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1281 · Cited by 31
Meij, B. P., & Mol, J. A. (2008) · Clinical Biochemistry of Domestic Animals · doi:10.1016/b978-0-12-370491-7.00019-2 · Cited by 7
Metadata
- Authors
- Lacroix, A., N′Diaye, N., Tremblay, J., & Hamet, P.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2001-02-01
- Volume
- 22
- Issue
- 1
- Pages
- 75-110
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2090912797
- Cited by
- 350
- References
- 341
- FWCI
- 20.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.